PubRank

J-Y Scoazec

Author PubWeight™ 28.62‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2006 5.86
2 TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch 2007 3.89
3 Prognosis of malignant intraductal papillary mucinous tumours of the pancreas after surgical resection. Comparison with pancreatic ductal adenocarcinoma. Gut 2002 1.85
4 Common dysregulation of Wnt/Frizzled receptor elements in human hepatocellular carcinoma. Br J Cancer 2008 1.59
5 A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region. Br J Cancer 2010 1.33
6 Diagnosis and treatment of biliary obstruction caused by portal cavernoma. Endoscopy 2003 1.20
7 Subcutaneous adipose tissue remodeling during the initial phase of weight gain induced by overfeeding in humans. J Clin Endocrinol Metab 2011 1.17
8 Transcriptional activation of cyclooxygenase-2 by tumor suppressor p53 requires nuclear factor-kappaB. Oncogene 2006 1.13
9 Preoperative chemoradiation in potentially resectable pancreatic adenocarcinoma: feasibility, treatment effect evaluation and prognostic factors, analysis of the SFRO-FFCD 9704 trial and literature review. Ann Oncol 2009 1.07
10 Acceleration of clear cell renal cell carcinoma growth in mice following bevacizumab/Avastin treatment: the role of CXCL cytokines. Oncogene 2011 1.00
11 P53-mediated upregulation of DcR1 impairs oxaliplatin/TRAIL-induced synergistic anti-tumour potential in colon cancer cells. Oncogene 2008 0.96
12 Liver transplantation for multiple angiomyolipomas complicating tuberous sclerosis complex. Gastroenterol Clin Biol 2010 0.90
13 Unresectable hepatocellular carcinoma: survival and prognostic factors after lipiodol chemoembolisation in 89 patients. Dig Liver Dis 2006 0.88
14 Carbimazole induced eosinophilic granulomatous vasculitis localized to the stomach. J Intern Med 2005 0.84
15 Rejection under alpha interferon therapy in liver transplant recipients. Am J Transplant 2007 0.84
16 Expression of beta-catenin in gastroenteropancreatic endocrine tumours: a study of 229 cases. J Clin Pathol 2006 0.82
17 TP63 P2 promoter functional analysis identifies β-catenin as a key regulator of ΔNp63 expression. Oncogene 2011 0.82
18 Introduction of mycophenolate mofetil in maintenance liver transplant recipients: what can we expect? Results of a 10-year experience. Transplant Proc 2010 0.80
19 Characterization of neuro-endocrine tumors in an athymic nude mouse model using dedicated synchronization strategies for T2-weigted MR imaging at 7T. Conf Proc IEEE Eng Med Biol Soc 2007 0.79
20 [Imaging features of osseous and extra-osseous involvement in Erdheim-Chester disease]. J Radiol 2011 0.77
21 Plasma ribavirin concentrations during treatment of recurrent hepatitis C with peginterferon alpha-2b and ribavirin combination after liver transplantation. J Viral Hepat 2006 0.76
22 [Histologic assessment of treatment effect of preoperative chemoradiation in patients presenting with resectable pancreatic adenocarcinoma]. Cancer Radiother 2010 0.76
23 Synchronisation strategies in T2-weighted MR imaging for detection of liver lesions: Application on a nude mouse model. Biomed Imaging Interv J 2007 0.75
24 Multimodal imaging for the detection and characterization of liver lesions in a mouse model of neuroendocrine tumor. Gastroenterol Clin Biol 2008 0.75
25 [A proteomic approach of the endocrine tumors]. Ann Endocrinol (Paris) 2008 0.75
26 [Bile duct involvement in autoimmune pancreatitis: classification and treatment]. Gastroenterol Clin Biol 2008 0.75
27 Malignant melanoma presenting as an ampullary tumour. Histopathology 2002 0.75
28 [Endocrine digestive tumors: pathogenesis, diagnosis and classification]. Ann Pathol 2006 0.75